BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cupp MA, Cariolou M, Tzoulaki I, Aune D, Evangelou E, Berlanga-Taylor AJ. Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. BMC Med 2020;18:360. [PMID: 33213430 DOI: 10.1186/s12916-020-01817-1] [Cited by in Crossref: 74] [Cited by in F6Publishing: 86] [Article Influence: 24.7] [Reference Citation Analysis]
Number Citing Articles
1 Lin GS, Lu J, Lin J, Zheng HL, Xu BB, Xue Z, Wu D, Shen L, Zheng CH, Li P, Xie JW, Chen QY, Huang CM. Value of the Preoperative D-Dimer to Albumin Ratio for Survival and Recurrence Patterns in Gastric Cancer. Ann Surg Oncol 2023;30:1132-44. [PMID: 36284056 DOI: 10.1245/s10434-022-12625-7] [Reference Citation Analysis]
2 Fiore M, Ljevar S, Pasquali S, Morelli D, Callegaro D, Sanfilippo R, Barisella M, Sangalli C, Miceli R, Gronchi A. Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study. Clin Cancer Res 2023;29:614-20. [PMID: 36478176 DOI: 10.1158/1078-0432.CCR-22-2897] [Reference Citation Analysis]
3 Mullally WJ, Greene J, Jordan EJ, Horgan AM, O'Connor M, Calvert PM. The prognostic value of the derived neutrophil-to-lymphocyte ratio (dNLR) in patients treated with immune checkpoint inhibitors. Ir J Med Sci 2023;192:83-7. [PMID: 35304710 DOI: 10.1007/s11845-022-02982-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Li D, Li J, Zhao C, Liao X, Liu L, Xie L, Shang W. Diagnostic value of procalcitonin, hypersensitive C-reactive protein and neutrophil-to-lymphocyte ratio for bloodstream infections in pediatric tumor patients. Clin Chem Lab Med 2022. [PMID: 36367370 DOI: 10.1515/cclm-2022-0801] [Reference Citation Analysis]
5 Kryvoruchko IA, Staikov P, Boyko VV, Sartelli M, Ivanova YV, Honcharov A, Gramatiuk S, Sargsyan K. Physiological stress level and screening for malnutrition as preoperative predictors of postoperative complications in pancreatic surgery: A retrospective study.. [DOI: 10.21203/rs.3.rs-2466680/v1] [Reference Citation Analysis]
6 Gu M, Han X, Liu X, Sui F, Zhang Q, Pan S. Predictive Value of Annenxin A1 for Disease Severity and Prognosis in Patients with Community-Acquired Pneumonia. Diagnostics 2023;13:396. [DOI: 10.3390/diagnostics13030396] [Reference Citation Analysis]
7 Tunay B, Olmez OF, Bilici A, Bayramgil A, Cavusoglu GD, Oz H. The modified Glasgow prognostic score (MGPS) and the mortality prediction model II (MPM II) can predict mortality in patients with breast cancer admitted to intensive care: A retrospective cohort study. J Surg Med 2023;7:6-10. [DOI: 10.28982/josam.7606] [Reference Citation Analysis]
8 Nonami A, Matsuo R, Funakoshi K, Nakayama T, Goto S, Iino T, Takaishi S, Mizuno S, Akashi K, Eto M. Prospective study of adoptive activated αβT lymphocyte immunotherapy for refractory cancers: development and validation of a response scoring system. Cytotherapy 2023;25:76-81. [PMID: 36253253 DOI: 10.1016/j.jcyt.2022.09.007] [Reference Citation Analysis]
9 Khanmohammadi S, Rezaei N. Tumor Associated Neutrophils (TANs) and Cancer Metastasis. Handbook of Cancer and Immunology 2023. [DOI: 10.1007/978-3-030-80962-1_67-1] [Reference Citation Analysis]
10 Gawiński C, Hołdakowska A, Wyrwicz L. Correlation between Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Extramural Vascular Invasion (EMVI) in Locally Advanced Rectal Cancer. Curr Oncol 2022;30:545-58. [PMID: 36661692 DOI: 10.3390/curroncol30010043] [Reference Citation Analysis]
11 Gao C, Tong YX, Zhu L, Dan Zeng CD, Zhang S. Short-term prognostic role of peripheral lymphocyte subsets in patients with gastric cancer. Int Immunopharmacol 2022;115:109641. [PMID: 36584574 DOI: 10.1016/j.intimp.2022.109641] [Reference Citation Analysis]
12 Guven DC, Erul E, Yilmaz F, Yasar S, Yildirim HC, Ercan F, Kaygusuz Y, Cayiroz K, Ucdal MT, Yesil F, Yazici G, Cengiz M, Gullu I, Aksoy S. The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2022. [DOI: 10.1007/s00405-022-07804-x] [Reference Citation Analysis]
13 Li C, Wan S, Li W, Wang Y, Li B, Chen Y, Sun P, Lyu J. Higher Neutrophil to Lymphocyte Ratio at Admission is Association with Post-PCI Depressive Symptoms in Patients with ACS. Neuropsychiatr Dis Treat 2022;18:2981-90. [PMID: 36578901 DOI: 10.2147/NDT.S387582] [Reference Citation Analysis]
14 You JF, Hsu YJ, Chern YJ, Cheng CC, Jong BK, Liao CK, Hsieh PS, Hsu HC, Tsai WS. Preoperative Cancer Inflammation Prognostic Index as a Superior Predictor of Short- and Long-Term Outcomes in Patients with Stage I-III Colorectal Cancer after Curative Surgery. Cancers (Basel) 2022;14. [PMID: 36551717 DOI: 10.3390/cancers14246232] [Reference Citation Analysis]
15 Xiuqiong Chen, Zhaona Li, Jing Zhou, Qianhui Wei, Xinyue Wang, Richeng Jiang. Identification of prognostic factors and nomogram model for patients with advanced lung cancer receiving immune checkpoint inhibitors. PeerJ 2022;10:e14566. [PMID: 36540802 DOI: 10.7717/peerj.14566] [Reference Citation Analysis]
16 Radulescu PM, Davitoiu DV, Baleanu VD, Padureanu V, Ramboiu DS, Surlin MV, Bratiloveanu TC, Georgescu EF, Streba CT, Mercut R, Caluianu EI, Trasca ET, Radulescu D. Has COVID-19 Modified the Weight of Known Systemic Inflammation Indexes and the New Ones (MCVL and IIC) in the Assessment as Predictive Factors of Complications and Mortality in Acute Pancreatitis? Diagnostics (Basel) 2022;12. [PMID: 36553125 DOI: 10.3390/diagnostics12123118] [Reference Citation Analysis]
17 Braga A, Canelas AC, Torres B, Maesta I, Giongo Pedrotti L, Bessel M, Vieira Dos Santos Esteves AP, Amim Junior J, Rezende Filho J, Elias KM, Horowitz NS, Berkowitz RS. Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia. PLoS One 2022;17:e0277892. [PMID: 36454778 DOI: 10.1371/journal.pone.0277892] [Reference Citation Analysis]
18 Ren W, Xu Y, Yang C, Cheng L, Yao P, Fu S, Han J, Zhuo D. Development and validation of a predictive model for diagnosing prostate cancer after transperineal prostate biopsy. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1038177] [Reference Citation Analysis]
19 Tian BW, Yang YF, Yang CC, Yan LJ, Ding ZN, Liu H, Xue JS, Dong ZR, Chen ZQ, Hong JG, Wang DX, Han CL, Mao XC, Li T. Systemic immune-inflammation index predicts prognosis of cancer immunotherapy: systemic review and meta-analysis. Immunotherapy 2022;14:1481-96. [PMID: 36537255 DOI: 10.2217/imt-2022-0133] [Reference Citation Analysis]
20 Liu Y, Zhang Z, Han D, Zhao Y, Yan X, Cui S. Association between environmental chemicals co-exposure and peripheral blood immune-inflammatory indicators. Front Public Health 2022;10:980987. [PMID: 36483254 DOI: 10.3389/fpubh.2022.980987] [Reference Citation Analysis]
21 Wan M, Ding Y, Mao C, Ma X, Li N, Xiao C, Qian J, Jiang H, Zheng Y, Wu L, Teng L, Xu N. Association of inflammatory markers with survival in patients with advanced gastric cancer treated with immune checkpoint inhibitors combined with chemotherapy as first line treatment. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1029960] [Reference Citation Analysis]
22 Zhou Q, Jia R, Dang J. Correlation between the Neutrophil-to-Lymphocyte Ratio and Multiple Sclerosis: Recent Understanding and Potential Application Perspectives. Neurology Research International 2022;2022:1-10. [DOI: 10.1155/2022/3265029] [Reference Citation Analysis]
23 Zhang W, Wang W, Wu J, Tian J, Yan W, Yuan Y, Yao Y, Shang A, Quan W. Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis. Front Oncol 2022;12:942964. [PMID: 36353553 DOI: 10.3389/fonc.2022.942964] [Reference Citation Analysis]
24 Ma Q, Hui Y, Yang B, Li J, Ma D, Huang B. Identification and validation of a ten Cuproptosis-related lncRNA prognostic signature for Stomach Adenocarcinoma.. [DOI: 10.21203/rs.3.rs-2161455/v1] [Reference Citation Analysis]
25 Schröder S, Heck J, Groh A, Frieling H, Bleich S, Kahl KG, Bosch JJ, Krichevsky B, Schulze-westhoff M. White Blood Cell and Platelet Counts Are Not Suitable as Biomarkers in the Differential Diagnostics of Dementia. Brain Sciences 2022;12:1424. [DOI: 10.3390/brainsci12111424] [Reference Citation Analysis]
26 Brkic FF, Stoiber S, Al-gboore S, Quint C, Schnoell J, Scheiflinger A, Heiduschka G, Brunner M, Kadletz-wanke L. Evaluation of the Prognostic Capacity of a Novel Survival Marker in Patients with Sinonasal Squamous Cell Carcinoma. Nutrients 2022;14:4337. [DOI: 10.3390/nu14204337] [Reference Citation Analysis]
27 Kast RE. High Neutrophil-to-Lymphocyte Ratio Facilitates Cancer Growth-Currently Marketed Drugs Tadalafil, Isotretinoin, Colchicine, and Omega-3 to Reduce It: The TICO Regimen. Cancers (Basel) 2022;14:4965. [PMID: 36230888 DOI: 10.3390/cancers14194965] [Reference Citation Analysis]
28 Yang Z, Zhang D, Zeng H, Fu Y, Hu Z, Pan Y, Chen J, Wang J, Zhang Y, Zhou Z, Xu L, Hu D, Chen M. Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma. J Inflamm Res 2022;15:5721-31. [PMID: 36238770 DOI: 10.2147/JIR.S385921] [Reference Citation Analysis]
29 Barcellini A, Fontana G, Maria Filippini D, Ronchi S, Bonora M, Vischioni B, Ingargiola R, Maria Camarda A, Loap P, Facchinetti N, Licitra L, Baroni G, Orlandi E. Exploring the role of neutrophil-to-lymphocyte ratio and blood chemistry in head and neck adenoid cystic carcinomas treated with carbon ion radiotherapy. Radiotherapy and Oncology 2022. [DOI: 10.1016/j.radonc.2022.10.027] [Reference Citation Analysis]
30 Cerrito L, Ainora ME, Mosoni C, Borriello R, Gasbarrini A, Zocco MA. Prognostic Role of Molecular and Imaging Biomarkers for Predicting Advanced Hepatocellular Carcinoma Treatment Efficacy. Cancers 2022;14:4647. [DOI: 10.3390/cancers14194647] [Reference Citation Analysis]
31 Gkantzios A, Tsiptsios D, Karatzetzou S, Kitmeridou S, Karapepera V, Giannakou E, Vlotinou P, Aggelousis N, Vadikolias K. Stroke and Emerging Blood Biomarkers: A Clinical Prospective. Neurology International 2022;14:784-803. [DOI: 10.3390/neurolint14040065] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Rebuzzi SE, Prelaj A, Friedlaender A, Cortellini A, Addeo A, Genova C, Naqash AR, Auclin E, Mezquita L, Banna GL. Prognostic scores including peripheral blood-derived inflammatory indices in patients with advanced non-small-cell lung cancer treated with immune checkpoint inhibitors. Crit Rev Oncol Hematol 2022;179:103806. [PMID: 36087850 DOI: 10.1016/j.critrevonc.2022.103806] [Reference Citation Analysis]
33 Hu Z, Zhou J, Li Y, Luan Y, Li H, Jia B, Xie Z, Cheng B, Wu T. Peripheral immune signature resembles tumor microenvironment and predicts clinical outcomes in head and neck squamous cell carcinoma. Front Immunol 2022;13:915207. [DOI: 10.3389/fimmu.2022.915207] [Reference Citation Analysis]
34 Yilmaz H, Nigdelioglu B, Aytac A, Turan M, Oktay E, Yersal O, Barutca S. The prognostic importance of glucose-to-lymphocyte ratio and uric acid in metastatic breast cancer patients treated with Cdk 4/6 inhibitors. Future Oncol 2022. [PMID: 36062468 DOI: 10.2217/fon-2022-0464] [Reference Citation Analysis]
35 Kwak JS, Kim SG, Lee SE, Choi WJ, Yoon DS, Choi IS, Moon JI, Sung NS, Kwon SU, Bae IE, Lee SJ, Roh SJ. The role of postoperative neutrophil-to-lymphocyte ratio as a predictor of postoperative major complications following total gastrectomy for gastric cancer. Ann Surg Treat Res 2022;103:153-9. [PMID: 36128035 DOI: 10.4174/astr.2022.103.3.153] [Reference Citation Analysis]
36 Morita Y, Kitazawa M, Yagi C, Takahashi K, Ohshima S, Yamagishi T, Izumi S, Horii A. Locations and Predictive Factors of Hypertrophic Pachymeningitis in Otitis Media With Antineutrophil Cytoplasmic Antigen-Associated Vasculitis. Otol Neurotol 2022;43:e835-40. [PMID: 35960882 DOI: 10.1097/MAO.0000000000003610] [Reference Citation Analysis]
37 Aziz MH, van der Meulen J, Mustafa DAM, van Eijck CHJ. Fat-Soluble Vitamin Deficiencies and Disruption of the Immune System in Pancreatic Cancer: A Vicious Cycle. Pancreas 2022;51:923-9. [PMID: 36607936 DOI: 10.1097/MPA.0000000000002128] [Reference Citation Analysis]
38 Zhang K, Zhang X, Zhang Q, Ruan G, Song M, Xie H, Zhang H, Li X, Yang M, Liu Y, Li Q, Ge Y, Liu X, Lin S, Li W, Xu H, Deng L, Shi H. Association between the Lymphocyte-to-C-Reactive Protein Ratio and Survival Outcomes in Cancer Patients with GLIM-Defined Malnutrition: A Multicenter Study. J Nutr Health Aging. [DOI: 10.1007/s12603-022-1835-3] [Reference Citation Analysis]
39 Xiong L, Fan C, Song J, Wan Y, Lin X, Su Z, Qiu J, Wu W, He Z, Wu Y, Yang X. Associations of long-term cadmium exposure with peripheral white blood cell subtype counts and indices in residents of cadmium-polluted areas. Chemosphere 2022;:135946. [PMID: 36007735 DOI: 10.1016/j.chemosphere.2022.135946] [Reference Citation Analysis]
40 Guven DC, Sahin TK, Erul E, Cakir IY, Ucgul E, Yildirim HC, Aktepe OH, Erman M, Kilickap S, Aksoy S, Yalcin S. The Association between Early Changes in Neutrophil-Lymphocyte Ratio and Survival in Patients Treated with Immunotherapy. JCM 2022;11:4523. [DOI: 10.3390/jcm11154523] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Wan H, Lu S, Xu L, Yuan K, Xiao Y, Xie K, Wu H. Immune-Related Biomarkers Improve Performance of Risk Prediction Models for Survival in Patients With Hepatocellular Carcinoma. Front Oncol 2022;12:925362. [DOI: 10.3389/fonc.2022.925362] [Reference Citation Analysis]
42 Papadopoulos E, Abu Helal A, Berger A, Jin R, Romanovsky L, Monginot S, Alibhai SMH. Objective measures of physical function and their association with cognitive impairment in older adults with cancer prior to treatment. J Geriatr Oncol 2022:S1879-4068(22)00173-4. [PMID: 35879200 DOI: 10.1016/j.jgo.2022.07.007] [Reference Citation Analysis]
43 Okunade KS, John‐olabode S, Ohazurike EO, Soibi‐harry A, Osunwusi B, Anorlu RI. Predictors of early mortality risk in patients with epithelial ovarian cancer. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.717] [Reference Citation Analysis]
44 Huang S, Fan H, Shi Y, Hu Y, Gu Z, Chen Y. Immune biomarkers are associated with poststroke fatigue at six months in patients with ischemic stroke. Journal of Clinical Neuroscience 2022;101:228-33. [DOI: 10.1016/j.jocn.2022.05.020] [Reference Citation Analysis]
45 Park JS, Yu JI, Lim DH, Nam H, Kim YI, Lee J, Kang WK, Park SH, Kim ST, Hong JY, Sohn TS, Lee JH, An JY, Choi MG, Bae JM. Clinical Significance of Preoperative Hematological Parameters in Patients with D2-Resected, Node-Positive Stomach Cancer. Biomedicines 2022;10:1565. [DOI: 10.3390/biomedicines10071565] [Reference Citation Analysis]
46 Zhang X, Wang D, Sun T, Li W, Dang C. Advanced lung cancer inflammation index (ALI) predicts prognosis of patients with gastric cancer after surgical resection. BMC Cancer 2022;22:684. [PMID: 35729545 DOI: 10.1186/s12885-022-09774-z] [Reference Citation Analysis]
47 Chen L, Zhao R, Sun H, Huang R, Pan H, Zuo Y, Zhang L, Xue Y, Li X, Song H. The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors. Front Pharmacol 2022;13:833584. [DOI: 10.3389/fphar.2022.833584] [Reference Citation Analysis]
48 Hadjigol S, Shah BA, O’brien-simpson NM. The ‘Danse Macabre’—Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes. Front Immunol 2022;13:894021. [DOI: 10.3389/fimmu.2022.894021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Jarmuzek P, Kot M, Defort P, Stawicki J, Komorzycka J, Nowak K, Tylutka A, Zembron-Lacny A. Prognostic Values of Combined Ratios of White Blood Cells in Glioblastoma: A Retrospective Study. J Clin Med 2022;11:3397. [PMID: 35743468 DOI: 10.3390/jcm11123397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Zinellu A, Zinellu E, Pau MC, Carru C, Pirina P, Fois AG, Mangoni AA. A Comprehensive Systematic Review and Meta-Analysis of the Association between the Neutrophil-to-Lymphocyte Ratio and Adverse Outcomes in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. J Clin Med 2022;11:3365. [PMID: 35743436 DOI: 10.3390/jcm11123365] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
51 Smith L, Cata JP, Forget P. Immunological Insights into Opioid-Free Anaesthesia in Oncological Surgery: A Scoping Review. Curr Oncol Rep 2022. [PMID: 35633449 DOI: 10.1007/s11912-022-01300-5] [Reference Citation Analysis]
52 Spieler B, Giret TM, Welford S, Totiger TM, Mihaylov IB. Lung Inflammation Predictors in Combined Immune Checkpoint-Inhibitor and Radiation Therapy—Proof-of-Concept Animal Study. Biomedicines 2022;10:1173. [DOI: 10.3390/biomedicines10051173] [Reference Citation Analysis]
53 Zhou Z, Zhang Y, Pan Y, Yang X, Li L, Gao C, He C. A Novel Neutrophil-Based Biomarker to Monitor Disease Activity and Predict Response to Infliximab Therapy in Patients With Ulcerative Colitis. Front Med (Lausanne) 2022;9:872831. [PMID: 35572985 DOI: 10.3389/fmed.2022.872831] [Reference Citation Analysis]
54 Sarkarova MR, Maevskaya MV. Prognostic and diagnostic value of the ratio of neutrophils to lymphocytes of patients with diseases of the gastrointestinal tract and liver. Medicinskij sovet 2022. [DOI: 10.21518/2079-701x-2022-16-7-60-68] [Reference Citation Analysis]
55 Matsunaga T, Saito H, Osaki T, Takahashi S, Iwamoto A, Fukuda K, Taniguchi K, Kuroda H, Takeuchi T, Sugamura K, Sumi K, Katano K, Shishido Y, Miyatani K, Fujiwara Y. Impact of geriatric nutritional risk index on outcomes after gastrectomy in elderly patients with gastric cancer: a retrospective multicenter study in Japan. BMC Cancer 2022;22:540. [PMID: 35549906 DOI: 10.1186/s12885-022-09638-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Li L, Wang Y, He X, Li Z, Lu M, Gong T, Chang Q, Lin J, Liu C, Luo Y, Min L, Zhou Y, Tu C. Hematological Prognostic Scoring System Can Predict Overall Survival and Can Indicate Response to Immunotherapy in Patients With Osteosarcoma. Front Immunol 2022;13:879560. [DOI: 10.3389/fimmu.2022.879560] [Reference Citation Analysis]
57 Lin F, Zhang LP, Xie SY, Huang HY, Chen XY, Jiang TC, Guo L, Lin HX. Pan-Immune-Inflammation Value: A New Prognostic Index in Operative Breast Cancer. Front Oncol 2022;12:830138. [PMID: 35494034 DOI: 10.3389/fonc.2022.830138] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
58 Li L, Li Z, He X, Wang Y, Lu M, Gong T, Chang Q, Lin J, Luo Y, Min L, Zhou Y, Tu C. A Nutritional Metabolism Related Prognostic Scoring System for Patients With Newly Diagnosed Osteosarcoma. Front Nutr 2022;9:883308. [DOI: 10.3389/fnut.2022.883308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Lousa I, Belo L, Valente MJ, Rocha S, Preguiça I, Rocha-Pereira P, Beirão I, Mira F, Alves R, Reis F, Santos-Silva A. Inflammatory biomarkers in staging of chronic kidney disease: elevated TNFR2 levels accompanies renal function decline. Inflamm Res 2022. [PMID: 35471601 DOI: 10.1007/s00011-022-01574-2] [Reference Citation Analysis]
60 Takeda K, Sakayauchi T, Kubozono M, Katagiri Y, Umezawa R, Yamamoto T, Ishikawa Y, Takahashi N, Suzuki Y, Kishida K, Jingu K. Palliative radiotherapy for gastric cancer bleeding: a multi-institutional retrospective study. BMC Palliat Care 2022;21. [DOI: 10.1186/s12904-022-00943-2] [Reference Citation Analysis]
61 Chen J, Song P, Peng Z, Liu Z, Yang L, Wang L, Zhou J, Dong Q. The Controlling Nutritional Status (CONUT) Score and Prognosis in Malignant Tumors: A Systematic Review and Meta-Analysis. Nutr Cancer 2022;:1-18. [PMID: 35382655 DOI: 10.1080/01635581.2022.2059091] [Reference Citation Analysis]
62 Arulananda S, Segelov E. Sarcopenia and cancer-related inflammation measurements in advanced gastric and junctional cancers – Ready for prime time? Annals of Oncology 2022. [DOI: 10.1016/j.annonc.2022.04.008] [Reference Citation Analysis]
63 Liu Y, Ni J, Xiong Y, Wu C, He F. Neutrophil-to-lymphocyte ratio is associated with 28-day mortality in patients with severe fever with thrombocytopenia syndrome. BMC Infect Dis 2022;22. [DOI: 10.1186/s12879-022-07206-8] [Reference Citation Analysis]
64 Chen F, Chen D, Jin L, Xu C, Zhao W, Hu W. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and C-Reactive Protein/Albumin Ratio in Luminal Breast Cancers With HER2-Negativity. Front Oncol 2022;12:845935. [DOI: 10.3389/fonc.2022.845935] [Reference Citation Analysis]
65 Gawiński C, Michalski W, Mróz A, Wyrwicz L. Correlation between Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Tumor-Infiltrating Lymphocytes (TILs) in Left-Sided Colorectal Cancer Patients. Biology (Basel) 2022;11:385. [PMID: 35336759 DOI: 10.3390/biology11030385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Tian K, Li P, Zhang Y. Preoperative Predictors of Early Mortality Risk in People with Osteosarcoma of the Extremities Treated with Standard Therapy. CMAR 2022;Volume 14:437-47. [DOI: 10.2147/cmar.s340723] [Reference Citation Analysis]
67 Ozel I, Duerig I, Domnich M, Lang S, Pylaeva E, Jablonska J. The Good, the Bad, and the Ugly: Neutrophils, Angiogenesis, and Cancer. Cancers 2022;14:536. [DOI: 10.3390/cancers14030536] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
68 Wang JH, Chen YY, Kee KM, Wang CC, Tsai MC, Kuo YH, Hung CH, Li WF, Lai HL, Chen YH. The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab. Cancers (Basel) 2022;14:343. [PMID: 35053508 DOI: 10.3390/cancers14020343] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
69 Lue KH, Huang CH, Hsieh TC, Liu SH, Wu YF, Chen YH. Systemic Inflammation Index and Tumor Glycolytic Heterogeneity Help Risk Stratify Patients with Advanced Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitor Therapy. Cancers (Basel) 2022;14:309. [PMID: 35053473 DOI: 10.3390/cancers14020309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
70 Ramirez MF, Cata JP. Anesthesia Techniques and Long-Term Oncological Outcomes. Front Oncol 2021;11:788918. [PMID: 34956903 DOI: 10.3389/fonc.2021.788918] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
71 Hedbrant A, Eklund D, Andersson L, Bryngelsson IL, Persson A, Westberg H, Särndahl E. Effects on white blood cell counts and the NLRP3 inflammasome due to dust and cobalt exposure in the hard metal industry. Biomarkers 2021;:1-11. [PMID: 34872432 DOI: 10.1080/1354750X.2021.2013538] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Bristow CL, Reeves MAB, Winston R. Alphataxin, a Small-Molecule Drug That Elevates Tumor-Infiltrating CD4+ T Cells, in Combination With Anti-PD-1 Therapy, Suppresses Murine Renal Cancer and Metastasis. Front Oncol 2021;11:739080. [PMID: 34900690 DOI: 10.3389/fonc.2021.739080] [Reference Citation Analysis]
73 Ryu WK, Moon Y, Park MH, Lim JH, Kim YS, Lee KH, Kwak SM, Kim C, Nam HS. A Preliminary Study on the Prognostic Impact of Neutrophil to Lymphocyte Ratio of the Bronchoalveolar Lavage Fluid in Patients with Lung Cancer. Diagnostics (Basel) 2021;11:2201. [PMID: 34943437 DOI: 10.3390/diagnostics11122201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
74 Chan L, Karimi N, Morovati S, Alizadeh K, Kakish JE, Vanderkamp S, Fazel F, Napoleoni C, Alizadeh K, Mehrani Y, Minott JA, Bridle BW, Karimi K. The Roles of Neutrophils in Cytokine Storms. Viruses 2021;13:2318. [PMID: 34835125 DOI: 10.3390/v13112318] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
75 Biswas T, Gawdi R, Jindal C, Iyer S, Kang KH, Bajor D, Machtay M, Choi YM, Efird JT. Pretreatment neutrophil-to-lymphocyte ratio as an important prognostic marker in stage III locally advanced non-small cell lung cancer: confirmatory results from the PROCLAIM phase III clinical trial. J Thorac Dis 2021;13:5617-26. [PMID: 34795912 DOI: 10.21037/jtd-21-1018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
76 Wang X, Yang M, Ge Y, Tang M, Rao B, Chen Y, Xu H, Cong M, Guo Z, Shi H. Association of Systemic Inflammation and Malnutrition With Survival in Nasopharyngeal Carcinoma Undergoing Chemoradiotherapy: Results From a Multicenter Cohort Study. Front Oncol 2021;11:766398. [PMID: 34765561 DOI: 10.3389/fonc.2021.766398] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
77 Zheng K, Liu X, Ji W, Lu J, Cui J, Li W. The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors. J Inflamm Res 2021;14:5769-85. [PMID: 34764670 DOI: 10.2147/JIR.S334941] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
78 Hsiang CW, Huang WY, Yang JF, Shen PC, Dai YH, Wang YF, Lin CS, Chang WC, Lo CH. Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:1299-309. [PMID: 34765571 DOI: 10.2147/JHC.S334933] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
79 Zheng Z, Yang C, Cai C, Zhu H. The Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Predicts Disease-Free Survival in Resectable Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2021;13:7511-6. [PMID: 34621132 DOI: 10.2147/CMAR.S321326] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
80 Homa-Mlak I, Brzozowska A, Mlak R, Szudy-Szczyrek A, Małecka-Massalska T. Neutrophil-to-Lymphocyte Ratio as a Factor Predicting Radiotherapy Induced Oral Mucositis in Head Neck Cancer Patients Treated with Radiotherapy. J Clin Med 2021;10:4444. [PMID: 34640462 DOI: 10.3390/jcm10194444] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
81 Kim JH, Lee JH, Lee HS, Shin SJ, Park EJ, Cho ES, Baik SH, Lee KY, Kang J. Elevated Neutrophil-to-Lymphocyte Ratio in Perioperative Periods is Suggestive of Poor Prognosis in Patients with Colorectal Cancer. J Inflamm Res 2021;14:4457-66. [PMID: 34522115 DOI: 10.2147/JIR.S327443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Bauckneht M, Rebuzzi SE, Signori A, Frantellizzi V, Murianni V, Lodi Rizzini E, Mascia M, Lavelli V, Donegani MI, Ponzano M, Gaudiano A, Stazza ML, Licari M, Cavallini L, Laghi V, Cindolo L, Maggi M, Sciarra A, Mammucci P, Sambuceti G, Costa RP, Spanu A, Rubini G, Monari F, De Vincentis G, Fornarini G. The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study). Eur J Nucl Med Mol Imaging 2021. [PMID: 34486070 DOI: 10.1007/s00259-021-05550-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
83 Choi WM, Kim JY, Choi J, Lee D, Shim JH, Lim YS, Lee HC, Yoo C, Ryu MH, Ryoo BY, Kim KM. Kinetics of the neutrophil-lymphocyte ratio during PD-1 inhibition as a prognostic factor in advanced hepatocellular carcinoma. Liver Int 2021;41:2189-99. [PMID: 33966338 DOI: 10.1111/liv.14932] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
84 Missale F, Bugatti M, Mattavelli D, Lonardi S, Lombardi D, Nicolai P, Piazza C, Battocchio S, Bozzola AM, Calza S, Vermi W. Metavariables Resuming Host Immune Features and Nodal Involvement Are Associated with Oncological Outcomes in Oral Cavity Squamous Cell Carcinoma. Cells 2021;10:2203. [PMID: 34571850 DOI: 10.3390/cells10092203] [Reference Citation Analysis]
85 Mihaylov IB, Totiger TM, Giret TM, Wang D, Spieler B, Welford S. Toward prediction of abscopal effect in radioimmunotherapy: Pre-clinical investigation. PLoS One 2021;16:e0255923. [PMID: 34428218 DOI: 10.1371/journal.pone.0255923] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
86 Kinget L, Bechter O, Punie K, Debruyne PR, Brems H, Clement P, Roussel E, Van Herck Y, Albersen M, Baldewijns M, Schöffski P, Beuselinck B. Multitumor Case Series of Germline BRCA1, BRCA2 and CHEK2-Mutated Patients Responding Favorably on Immune Checkpoint Inhibitors. Curr Oncol 2021;28:3227-39. [PMID: 34449592 DOI: 10.3390/curroncol28050280] [Reference Citation Analysis]
87 Mushtaq MU, Shahzad M, Chaudhary SG, Luder M, Ahmed N, Abdelhakim H, Bansal R, Balusu R, DeJarnette S, Divine C, Kribs R, Shune L, Singh AK, Ganguly S, Abhyankar SH, McGuirk JP. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients. Transplant Cell Ther 2021;27:796.e1-7. [PMID: 34256172 DOI: 10.1016/j.jtct.2021.07.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 8.5] [Reference Citation Analysis]
88 Boscolo-Rizzo P, Zanelli E, Giudici F, Boscolo-Nata F, Cristalli G, Deganello A, Tomasoni M, Piazza C, Bossi P, Spinato G, Menegaldo A, Emanuelli E, Nicolai P, Bandolin L, Ciorba A, Pelucchi S, Lupato V, Giacomarra V, Molteni G, Marchioni D, Canzi P, Mauramati S, Fortunati A, Tofanelli M, Borsetto D, Fussey J, Tirelli G. Prognostic value of H-index in patients surgically treated for squamous cell carcinoma of the larynx. Laryngoscope Investig Otolaryngol 2021;6:729-37. [PMID: 34401497 DOI: 10.1002/lio2.603] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
89 Tolle F, Umansky V, Utikal J, Kreis S, Bréchard S. Neutrophils in Tumorigenesis: Missing Targets for Successful Next Generation Cancer Therapies? Int J Mol Sci 2021;22:6744. [PMID: 34201758 DOI: 10.3390/ijms22136744] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
90 Barros B, Oliveira M, Morais S. Firefighters' occupational exposure: Contribution from biomarkers of effect to assess health risks. Environ Int 2021;156:106704. [PMID: 34161906 DOI: 10.1016/j.envint.2021.106704] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
91 Meng L, Tang Q, Zhao J, Wang Z, Wei L, Wei Q, Yin L, Luo S, Song J. S100A9 Derived From Myeloma Associated Myeloid Cells Promotes TNFSF13B/TNFRSF13B-Dependent Proliferation and Survival of Myeloma Cells. Front Oncol 2021;11:691705. [PMID: 34150664 DOI: 10.3389/fonc.2021.691705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
92 Mjaess G, Chebel R, Karam A, Moussa I, Pretot D, Abi Tayeh G, Sarkis J, Semaan A, Peltier A, Aoun F, Albisinni S, Roumeguère T. Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in urological tumors: an umbrella review of evidence from systematic reviews and meta-analyses. Acta Oncol 2021;60:704-13. [PMID: 33586577 DOI: 10.1080/0284186X.2021.1886323] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
93 Mentis AA, Garcia I, Jiménez J, Paparoupa M, Xirogianni A, Papandreou A, Tzanakaki G. Artificial Intelligence in Differential Diagnostics of Meningitis: A Nationwide Study. Diagnostics (Basel) 2021;11:602. [PMID: 33800653 DOI: 10.3390/diagnostics11040602] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
94 Kinoshita T, Goto T. Links between Inflammation and Postoperative Cancer Recurrence. J Clin Med 2021;10:E228. [PMID: 33435255 DOI: 10.3390/jcm10020228] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]